CareDx Inc. revises revenue guidance for the full year ended December 31, 2023. For the period, the company expects revenue to be in the range of $279 million to $280 million, which is above the high end of guidance for fiscal year 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.18 USD | +18.30% | +15.04% | -23.50% |
Apr. 16 | CareDx Appoints John Hanna as CEO, President | MT |
Apr. 16 | CareDx, Inc Appoints John W. Hanna as Chief Executive Officer | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.50% | 404M | |
-18.88% | 10.91B | |
+53.75% | 3.3B | |
-32.50% | 2.19B | |
-14.31% | 2.16B | |
-26.83% | 1.5B | |
+28.55% | 1.09B | |
-3.28% | 737M | |
-43.27% | 386M | |
+17.30% | 342M |
- Stock Market
- Equities
- CDNA Stock
- News CareDx, Inc
- CareDx, Inc Revises Revenue Guidance for the Full Year Ended December 31, 2023